Analysts Information
Quirk, CFA, WilliamSr Research AnalystWilliam Quirk is a managing director and senior research analyst at Piper Jaffray, focusing on the medical diagnostics and life science tools sectors. Prior to joining Piper Jaffray in 2006, Quirk worked in equity research at RBC Capital Markets in Minneapolis and at Paine Webber in New York. Quirk received a bachelor's degree in business from St. Norbert College and a master's degree in business from the Carlson School of Management at the University of Minnesota. He holds the Chartered Financial Analyst designation. | Associates:Clair, CFA, David |
| Universe Coverage: Health Care: Medical Diagnostics, Life Science Tools, European Medical Technology | |
| ABAX | Abaxis Inc. |
| AFFX | Affymetrix, Inc. |
| BEC | Beckman Coulter, Inc. |
| BDX | Becton, Dickinson and Company |
| BIM FP | bioMerieux |
| CPHD | Cepheid |
| EXAS | Exact Sciences Corporation |
| GNMK | GenMark Diagnostics, Inc. |
| GHDX | Genomic Health, Inc. |
| GPRO | Gen-Probe Incorporated |
| HOLX | Hologic, Inc. |
| IDXX | IDEXX Laboratories Inc. |
| ILMN | Illumina, Inc. |
| BLUD | Immucor, Inc. |
| LH | Laboratory Corporation of America Holdings |
| LMNX | Luminex Corporation |
| MASI | Masimo Corporation |
| MYGN | Myriad Genetics, Inc. |
| NSPH | Nanosphere, Inc. |
| QGEN | QIAGEN N.V. |
| DGX | Quest Diagnostics Incorporated |
| RMD | ResMed Inc. |
